RS50274B - Ob polipeptid i njegova dijagnostička i terapeutska primena - Google Patents
Ob polipeptid i njegova dijagnostička i terapeutska primenaInfo
- Publication number
- RS50274B RS50274B YU54995A YU54995A RS50274B RS 50274 B RS50274 B RS 50274B YU 54995 A YU54995 A YU 54995A YU 54995 A YU54995 A YU 54995A RS 50274 B RS50274 B RS 50274B
- Authority
- RS
- Serbia
- Prior art keywords
- polypeptide
- seq
- diagnostic
- body weight
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
OB polipeptid, naznačen time, što je odabran iz grupe koju čine: a) polipeptid čija je aminokiselinska sekvenca SEQ ID NO.2,4,5 ili 6; b) biološki aktivni fragment polipeptida iz (a) gde dati fragment modulira telesnu težinu životinje; c) polipeptid iz a) ili b) kod koga su izostavljene ili supstituisane aminokiseline na pozicijama koje ne utiču na strukturu ili funkciju polipeptida; d) OB polipeptid sposoban da modulira telesnu težinu, čija je sekvenca 83% ili više homologna sa OB polipeptidom čija je aminokiselinska sekvenca SEQ ID NOS. 2,4,5 ili 6; e) hemijski modifikovan polipeptid iz (a) do (d), tako što je za polipeptid vezana jedna ili više hemijskih grupa. Prijava sadrži još 14 nezavisnih i 30 zavisnih patentnih zahteva.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/292,345 US6001968A (en) | 1994-08-17 | 1994-08-17 | OB polypeptides, modified forms and compositions |
US08/347,563 US5935810A (en) | 1994-08-17 | 1994-11-30 | Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof |
US08/438,431 US6429290B1 (en) | 1994-08-17 | 1995-05-10 | OB polypeptides, modified forms and derivatives |
US08/483,211 US6309853B1 (en) | 1994-08-17 | 1995-06-07 | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
YU54995A YU54995A (sh) | 1998-05-15 |
RS50274B true RS50274B (sr) | 2009-07-15 |
Family
ID=46507740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU54995A RS50274B (sr) | 1994-08-17 | 1995-08-17 | Ob polipeptid i njegova dijagnostička i terapeutska primena |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR100584177B1 (sr) |
BR (1) | BRPI9508596B1 (sr) |
PE (1) | PE47396A1 (sr) |
RS (1) | RS50274B (sr) |
UA (1) | UA70911C2 (sr) |
-
1995
- 1995-08-17 UA UA97031161A patent/UA70911C2/uk unknown
- 1995-08-17 PE PE1995276599A patent/PE47396A1/es not_active Application Discontinuation
- 1995-08-17 BR BRPI9508596A patent/BRPI9508596B1/pt unknown
- 1995-08-17 KR KR1019970701038A patent/KR100584177B1/ko not_active IP Right Cessation
- 1995-08-17 RS YU54995A patent/RS50274B/sr unknown
Also Published As
Publication number | Publication date |
---|---|
KR970705631A (ko) | 1997-10-09 |
BRPI9508596B1 (pt) | 2018-11-27 |
UA70911C2 (uk) | 2004-11-15 |
KR100584177B1 (ko) | 2006-10-24 |
PE47396A1 (es) | 1996-12-02 |
YU54995A (sh) | 1998-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE60980T1 (de) | Neue, gegen coleoptera wirksame varietaet des bacillus thuringiensis sowie ein insektizid wirkendes, hieraus erhaeltliches praeparat bzw. toxin sowie deren verwendung zur bekaempfung von coleoptera. | |
PT839196E (pt) | Ctla-8 humana e utilizacoes de proteinas relacionadas com ctla-8 | |
RS51898B (sr) | Specifični agensi koji vezuju humani angiopoetin-2 | |
ES2140082T3 (es) | Composiciones peptidicas con actividad de tipo factor de crecimiento. | |
ES2081370T3 (es) | Gen y proteina de bacillus thuringiensis, y su utilizacion. | |
BR9713108A (pt) | Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células | |
BR9206578A (pt) | Seqüência de DNA sintético tendo melhorada atividade inseticida em milho. | |
DK0690872T3 (da) | Biologisk aktive peptider fra funktionelle domæner af baktericidt/permeabilitetsforøgende protein og anvendelser deraf | |
DE69942035D1 (de) | Menschliches parathyroidhormon, modifikationen, herstellung und verwendung | |
DE69824755D1 (de) | Cytokinähnliches polypeptid-10 aus säugetieren | |
ES2171417T3 (es) | Uso de aislados de bacillus thuringiensis para controlar plagas de la familia aphididae. | |
ATE278710T1 (de) | Antimikrobiell wirksame peptide | |
ATE246247T1 (de) | Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
BR0008785A (pt) | Variantes de polipeptìdeo com capacidade aumentada de ligação com a heparina | |
SE9101838D0 (sv) | Novel peptides and their use | |
ES2146214T3 (es) | Vacunas para actinobacillus pleuropneumoniae. | |
AR012849A1 (es) | Composicion farmaceutica antivirica. | |
DK0896615T3 (da) | Peptid fra opløselig form af acetylcholinesterase, der er aktivt som calcium-kanal-modulator | |
ES2129456T3 (es) | Procedimiento para el control de plagas de lepidopteros. | |
ATE378408T1 (de) | Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren | |
DE68917837T2 (de) | Peptid-Verbindungen. | |
RS50831B (sr) | Izolovano antitelo ili fragment antitela koji se specifično vezuju za rg1 polipeptid | |
RS50274B (sr) | Ob polipeptid i njegova dijagnostička i terapeutska primena | |
RS49520B (sr) | Antimikrobno aktivne smeše | |
ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen |